Cargando…
HIV-1 Entry, Inhibitors, and Resistance
Entry inhibitors represent a new class of antiretroviral agents for the treatment of infection with HIV-1. While resistance to other HIV drug classes has been well described, resistance to this new class is still ill defined despite considerable clinical use. Several potential mechanisms have been p...
Autores principales: | Lobritz, Michael A., Ratcliff, Annette N., Arts, Eric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187606/ https://www.ncbi.nlm.nih.gov/pubmed/21994672 http://dx.doi.org/10.3390/v2051069 |
Ejemplares similares
-
Elite Suppressor–Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics
por: Lassen, Kara G., et al.
Publicado: (2009) -
Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by
a Cyclic Peptide that Binds the Tat-Transactivating Response Element (TAR)
RNA
por: Lalonde, Matthew S., et al.
Publicado: (2011) -
HIV-1 Entry and Membrane Fusion Inhibitors
por: Xiao, Tianshu, et al.
Publicado: (2021) -
Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1
por: Klein, Katja, et al.
Publicado: (2021) -
Characterization of resistance to a potent d-peptide HIV entry inhibitor
por: Smith, Amanda R., et al.
Publicado: (2019)